You are here

Article info

Article menu

Download PDFPDF

XML
Original research
Palivizumab’s real-world effectiveness: a population-based study in Ontario, Canada, 1993–2017

Authors

  • Tiffany Fitzpatrick Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada ICES, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • James Dayre McNally Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Ontario, Canada Department of Pediatrics, Children’s Hospital of Eastern Ontario, University of Ottawa, Ottawa, Ontario, Canada PubMed articlesGoogle scholar articles
  • Therese A Stukel Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada ICES, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Jeffrey C Kwong Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada ICES, Toronto, Ontario, Canada Public Health Ontario, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Andrew S Wilton ICES, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • David Fisman Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Astrid Guttmann Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada ICES, Toronto, Ontario, Canada Division of Paediatric Medicine, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada Leong Centre for Healthy Children, University of Toronto, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Astrid Guttmann, ICES, Toronto, ON M4N3M5, Canada; astrid.guttmann{at}ices.on.ca
View Full Text

Citation

Fitzpatrick T, McNally JD, Stukel TA, et al
Palivizumab’s real-world effectiveness: a population-based study in Ontario, Canada, 1993–2017
Archives of Disease in Childhood 2021;106:173-179.

Publication history

  • Received April 23, 2020
  • Revised July 7, 2020
  • Accepted July 19, 2020
  • First published August 28, 2020.
Online issue publication 
January 19, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.